Search Results
68 items found for "Ping Chi"
- Dr. Josephine (Pina) Cardarelli - Dr. GPCR Podcast
Pina Cardarelli, CSO of GPCR Therapeutics.
- Integrative model of the FSH receptor reveals the structural role of the flexible hinge region
extracellular domain, which contains the hormone-binding site and is linked to the transmembrane domain by the hinge
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
HLGR2 RNAi led to a low pupation rate (45.00%), body malformation, abnormal wing expansion, failed cuticle Conclusion: HLGR2 is essential for the growth and development and wing expansion and maturation in H.
- The expression and clinical significance of GPR39 in colon cancer
significance of GPR39 was evaluated by analyzing the correlations with clinicopathological factors with the chi-square
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
., of the University of Oxford, has joined Exscientia as Chief Scientist of Biologics AI. Professor Deane joins Exscientia’s technology leadership team, reporting to Chief Technology Officer,
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Vraniak to the position of Chief Financial Officer (CFO), effective immediately. Mr. Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company Vraniak served as the Chief Financial Officer of electroCore, Inc. and was a key member of the management
- Exscientia welcomes Richard J. Law, as their new Chief Business Officer
Law, our newly named Chief Business Officer.
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
March 2022 Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief endocrine diseases and endocrine-related tumors, today announced the appointment of James Hassard as chief
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner by data from a Phase 3 bridging study of oliceridine injection compared to IV morphine, conducted in China success payments upon approval and commercialization milestones, as well as a 10% royalty on net sales in China commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that China
- Overview of adhesion GPCRs self-activation
Ping, Y.-Q., et al., Structural basis for the tethered peptide activation of adhesion GPCRs.
- Identification and functional characterization of the sulfakinin and sulfakinin receptor in the...
2022 Identification and functional characterization of the sulfakinin and sulfakinin receptor in the Chinese white pine beetle Dendroctonus armandi "The sulfakinin (SK) is an important signal molecule. However, there is no report on the functional role of SK in the Chinese white pine beetle, Dendroctonus
- Specific Functions of Melanocortin 3 Receptor (MC3R)
October 2022 "Melanocortin 3 receptor (MC3R) is a G-protein coupled receptor (GPCR) that is defined as a regulator of appetite/hunger balance mechanisms mostly up to date. In addition to its function about weight gain and appetite control mechanisms of MC3R, recent studies showed that MC3R controls growth, puberty, and circadian rhythms as well. Despite the drastic effects of the MC3R deficiency in humans and other mammals, its cellular mechanisms are still under investigation. In this review paper, we aimed to point out the importance of the MC3R regulations in three main concepts: 1) its impact on weight and appetite control, 2) the control of growth, puberty, and circadian rhythm, and, 3) its protein-protein interactions and cellular mechanisms." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, July 3 to 9, 2023
Graeme Milligan for receiving the Order of British Empire from King Charles III in recognition of his Graeme Milligan was awarded the Order of British Empire by King Charles III for services to Biochemical
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
approach to this problem by predicting potential resistance mutations before they are clinically observed (Pines BioRxiv (Cold Spring Harbor Laboratory) . https://doi.org/10.1101/2024.04.17.590000 Pines, G., Fankhauser
- 📰 GPCR Weekly News, May 1 to 7, 2023
Expectations, EPS Lags “As Precision Medicine is critical, we cannot think about one size fits all” Dr Pina Cardarelli, Chief Scientific Officer, GPCR Therapeutics Trevena to Participate in Three Upcoming Conferences
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Devki D Sukhtankar and Pina M Cardarelli's research: Burixafor Hydrobromide (GPC-100) effects on hematopoietic Christophe Arbet-Engels to Join as Chief Medical Officer GPCR Events, Meetings, and Webinars ONCORNET2.0
- 📰 GPCR Weekly News, July 24 to July 30, 2023
The Neuromedin U system: pharmacological implications for the treatment of obesity and binge eating behavior
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
A rational drug discovery campaign hinges on a deep understanding of how distinct molecules interact
- 📰 GPCR Weekly News, February 20 to 26, 2023
Industry News Josephine (Pina) Cardarelli from GPCR Therapeutics on Beyond Biotech Podcast Crinetics
- 📰 GPCR Weekly News, December 18 to 31, 2023
Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics
- Glyco-sulfo hotspots in the chemokine receptor system
the observed phenotype since many glycosyltransferases and the two TPSTs also carry O-glycosylation (King
- Decoding β-Arrestins: from Structure to function
states: methods and implications The formation of functional complexes involving GPCRs and β-arrestins hinges
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
Schedule a session with our Chief Match Maker. Direct line to the Dr. Jude Children's Research Hospital Welcomes Dr.
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Book a session with our Chief Match Maker. Direct line to the Dr.
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
site and a GPCR Paper with his team: Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China 6th, 2024 Industry News Nxera Pharma appoints experienced commercial R&D executive Makoto Sugita as Chief implications Structural and Molecular Insights into GPCR Function LYCHOS is a human hybrid of a plant-like PIN
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
calcium-binding photoprotein clytin II: Expression of the preferred human codon-optimized clytin II gene in Chinese
- Unlocking the Future of Medicine: Advancements in GPCR Research
oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation Chiara
- 📰 GPCR Weekly News, July 1 to 7, 2024
Sesquiterpenoid and Ambivalent Semiochemical, Activates Evolutionary Conserved Receptor OR11A1 Tongue-on-a-Chip